TrialBlood2010

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.

Helen E Heslop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.